Emily Sandbach
Internal Medicine · Colorado Springs, CONPI 1033289285
Payments from drug & device makers
Across 80 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$361
- GSK$128
- Nestle Healthcare Nutrition Inc.$94
- Lilly USA, LLC$83
- Biohaven Pharmaceuticals, Inc.$71
- Novo Nordisk$64
- plus $465 from 18 others
What the payments were for
- Food & beverage$1,266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $361 |
| GSK | 12 | $128 |
| Nestle Healthcare Nutrition Inc. | 5 | $94 |
| Lilly USA, LLC | 6 | $83 |
| Biohaven Pharmaceuticals, Inc. | 4 | $71 |
| Novo Nordisk | 4 | $64 |
| Pfizer | 4 | $60 |
| Boehringer Ingelheim | 3 | $54 |
| Hologic Sales And Service, LLC | 2 | $42 |
| Sunovion Pharmaceuticals Inc. | 2 | $35 |
| Tactile Systems Technology Inc | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Eisai Inc. | 2 | $26 |
| USWM, LLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Amgen | 1 | $19 |
| Baxter Healthcare | 1 | $18 |
| Merck | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
| Inogen, Inc. | 1 | $12 |
| Nevro Corp. | 1 | $11 |
How this compares
$1,266 in reported general payments places this provider in the 85th percentile of 1,430 internal medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 113 | $159,820 |
| JardianceEmpagliflozin | 98 | $139,035 |
| MounjaroTirzepatide | 76 | $116,717 |
| OzempicSemaglutide | 59 | $87,671 |
| VraylarCariprazine Hcl | 41 | $60,661 |
| ZenpepLipase/Protease/Amylase | 14 | $48,136 |
| EliquisApixaban | 28 | $47,832 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $44,814 |
| LinzessLinaclotide | 36 | $33,245 |
| FarxigaDapagliflozin Propanediol | 16 | $25,087 |
| XareltoRivaroxaban | 11 | $16,059 |
| MyrbetriqMirabegron | 20 | $16,052 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $12,918 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 69 | $11,876 |
| MovantikNaloxegol Oxalate | 13 | $5,496 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $83 | $276,537189 claims |
| Boehringer IngelheimJardiance | $54 | $139,03598 claims |
| AbbVieVraylar, Linzess | $361 | $93,90677 claims |
| Novo NordiskOzempic | $64 | $87,67159 claims |
| PfizerEliquis | $60 | $47,83228 claims |
| GSKTrelegy Ellipta | $128 | $44,81431 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $16,05220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,430 internal medicine providers in Colorado.
Other internal medicine in Colorado Springs
- Luke WebbColorado Springs$2.1M
- Steven BrodieColorado Springs$883K
- Royce SolanoColorado Springs$263K
- Samuel PiedadColorado Springs$154K
- Munni SelagamsettyColorado Springs$56K
- Jocelyn de YaoColorado Springs$35K
- Sridhar ReddyColorado Springs$21K
- Quinn HalversonColorado Springs$11K
- Pankaj NashikkarColorado Springs$10K
- Elizabeth CruzColorado Springs$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.